These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 30152863)
1. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis. Yi YY; Yi J; Zhu X; Zhang J; Zhou J; Tang X; Lin J; Wang P; Deng ZQ J Cell Physiol; 2019 Apr; 234(4):3711-3719. PubMed ID: 30152863 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia. Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. Wu S; Du Y; Beckford J; Alachkar H J Transl Med; 2018 Jun; 16(1):170. PubMed ID: 29925392 [TBL] [Abstract][Full Text] [Related]
4. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients. Zhou J; Zhou LY; Tang X; Zhang J; Zhai LL; Yi YY; Yi J; Lin J; Qian J; Deng ZQ BMC Cancer; 2019 Sep; 19(1):930. PubMed ID: 31533653 [TBL] [Abstract][Full Text] [Related]
5. The role of circular RNA plasmacytoma variant translocation 1 as a biomarker for prognostication of acute myeloid leukemia. Chen T; Chen F Hematology; 2021 Dec; 26(1):1018-1024. PubMed ID: 34871521 [TBL] [Abstract][Full Text] [Related]
6. Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 Axis. Chen Y; Li BX; Niu TT; Yang SJ; Wu LC; Shi LH; Zou DB; Wu NN; Sheng LX; Yan X; Ouyang GF; Mu QT Curr Med Sci; 2024 Jun; 44(3):611-622. PubMed ID: 38842772 [TBL] [Abstract][Full Text] [Related]
7. Serum hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia. Guo L; Kou R; Song Y; Li G; Jia X; Li Z; Zhang Y J Clin Lab Anal; 2022 Apr; 36(4):e24337. PubMed ID: 35297094 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia. Zhou JD; Yang L; Zhu XW; Wen XM; Yang J; Guo H; Chen Q; Yao DM; Ma JC; Lin J; Qian J Int J Clin Exp Pathol; 2015; 8(5):5336-44. PubMed ID: 26191235 [TBL] [Abstract][Full Text] [Related]
9. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia. Jiang Z; Yu Q; Luo X J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217 [TBL] [Abstract][Full Text] [Related]
10. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients. Xiong T; Xia L; Song Q J Clin Lab Anal; 2023 Feb; 37(3):e24835. PubMed ID: 36644997 [TBL] [Abstract][Full Text] [Related]
12. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176 [TBL] [Abstract][Full Text] [Related]
13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
14. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia. Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964 [TBL] [Abstract][Full Text] [Related]
15. Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia. Shen Y; Jia Y; Zhang R; Chen H; Feng Y; Li F; Wang T; Bai J; He A; Yang Y Acta Haematol; 2022; 145(2):176-183. PubMed ID: 34879367 [TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia. Zhao J; Wang G; Yan G; Zheng M; Li H; Bai Y; Zheng X; Chen Z BMC Cancer; 2024 Sep; 24(1):1172. PubMed ID: 39304860 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia. Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855 [TBL] [Abstract][Full Text] [Related]
18. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia. Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884 [TBL] [Abstract][Full Text] [Related]
19. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia. Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469 [TBL] [Abstract][Full Text] [Related]
20. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia. Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]